Athira Pharma, Inc.
Industry: Life Sciences ・ $ATHA on Nasdaq
Insider Sale
+$725
-1.29%
Shares
Shares Volume: 1,272 Shares
Average Share Price: $0.57
INSIDER
Gengos Andrew
CFO and Chief Business Officer (Officer)
reported on Sep 5 2024
traded on Sep 3 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 97,532 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $2,585.2 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 2 / 14 |
| P/S VALUE RATIO | 19.653 |
| AVERAGE SALE VALUE | $5,577.76 |
| COMPANY PREVIOUS TRADES |